Theresa Heggie

Companies

• ProQR Therapeutics N.V.Board member Mar 18, 2026 to now¹
• BioCryst PharmaceuticalsBoard member Dec 6, 2018 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BioCryst Pharmaceuticals BCRX80,646 shares³$644.0K at $7.99Jun 11, 2026
• PTProQR Therapeutics N.V. PRQR43,623 shares⁴$58.2K at $1.33Mar 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 11, 2026Granted 15,294 shares of BioCryst Pharmaceuticals³
• Mar 20, 2026Sold 49,933 shares at $10.11 of BioCryst Pharmaceuticals⁵
• Mar 20, 2026Exercised options 49,933 shares at $6.30 of BioCryst Pharmaceuticals⁵
• Aug 13, 2025Sold 70,000 shares at $8.51 of BioCryst Pharmaceuticals⁶
• Aug 13, 2025Exercised options 40,000 shares at $5.41 of BioCryst Pharmaceuticals⁶
• Aug 13, 2025Exercised options 30,000 shares at $2.91 of BioCryst Pharmaceuticals⁶
• Jun 12, 2025Granted 12,500 shares of BioCryst Pharmaceuticals⁷
• Jun 14, 2024Sold 6,698 shares at $6.11 of BioCryst Pharmaceuticals⁸
• Jun 12, 2024Granted 6,820 shares of BioCryst Pharmaceuticals⁸
• May 31, 2024Granted 870 shares at $6.46 of BioCryst Pharmaceuticals⁹
• Feb 29, 2024Granted 999 shares at $5.63 of BioCryst Pharmaceuticals¹⁰
• Nov 30, 2023Granted 956 shares at $5.88 of BioCryst Pharmaceuticals¹¹
• Aug 31, 2023Granted 791 shares at $7.11 of BioCryst Pharmaceuticals¹²
• Jun 13, 2023Granted 16,745 shares of BioCryst Pharmaceuticals¹³
• May 31, 2023Granted 680 shares at $8.27 of BioCryst Pharmaceuticals¹⁴
• Feb 28, 2023Granted 635 shares at $8.85 of BioCryst Pharmaceuticals¹⁵
• Nov 30, 2022Granted 421 shares at $13.36 of BioCryst Pharmaceuticals¹⁶
• Aug 31, 2022Granted 404 shares at $13.90 of BioCryst Pharmaceuticals¹⁷
• Jun 7, 2022Granted 12,866 shares of BioCryst Pharmaceuticals¹⁸
• May 31, 2022Granted 1,138 shares at $9.31 of BioCryst Pharmaceuticals¹⁹
• Feb 28, 2022Granted 602 shares at $16.61 of BioCryst Pharmaceuticals²⁰
• Nov 30, 2021Granted 829 shares at $12.06 of BioCryst Pharmaceuticals²¹